References
Babitt JL,
Huang FW,
Wrighting DM et al.
(2006)
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.
Nature Genetics
38:
531–539.
Barrios‐Rodiles M,
Brown KR,
Ozdamar B et al.
(2005)
High‐throughput mapping of a dynamic signaling network in mammalian cells.
Science
307:
1621–1625.
Baur ST,
Mai JJ and
Dymecki SM
(2000)
Combinatorial signaling through BMP receptor IB and GDF5: shaping of the distal mouse limb and the genetics of distal limb diversity.
Development
127:
605–619.
Chen YG,
Hata A,
Lo RS et al.
(1998)
Determinants of specificity in TGF‐β signal transduction.
Genes and development
12:
2144–2152.
Daluiski A,
Engstrand T,
Bahamonde ME et al.
(2001)
Bone morphogenetic protein‐3 is a negative regulator of bone density.
Nature Genetics
27:
84–88.
ten Dijke P,
Yamashita H,
Sampath TK et al.
(1994)
Identification of type I receptors for osteogenic protein and bone morphogenetic protein‐4.
Journal of Biological Chemistry
269:
16985–16988.
Foletta VC,
Lim MA,
Soosairajah J et al.
(2003)
Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1.
Journal of Cell Biology
162:
1089–1098.
Fuentealba LC,
Eivers E,
Ikeda A et al.
(2007)
Integrating Patterning Signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal.
Cell
131:
980–993.
Graff JM,
Bansal A and
Melton DA
(1996)
Xenopus mad proteins transduce distinct subsets of signals for the TGFβ superfamily.
Cell
85:
479–489.
Groppe J,
Greenwald J,
Wiater E et al.
(2002)
Structural basis of BMP signalling inhibition by the cystine knot protein Noggin.
Nature
420:
636–642.
Hoodless PA,
Haerry T,
Abdollah S et al.
(1996)
MADR1, a MAD‐related protein that functions in BMP2 signalling pathways.
Cell
85:
489–500.
Itoh S and
ten Dijke P
(2007)
Negative regulation of TGF‐β receptor/Smad signal transduction.
Current Opinion in Cell Biology
19:
176–184.
Korchynskyi O and
ten Dijke P
(2002)
Identification and functional characterization of distinct critically important bone morphogenetic protein‐specific response elements in the Id1 promoter.
Journal of Biological Chemistry
277:
4883–4891.
Lagna G,
Hata A,
Hemmati‐Brivanlou A and
Massagué J
(1996)
Partnership between DPC4 and SMAD proteins in TGFβ signalling pathways.
Nature
383:
832–836.
Larraín J,
Oelgeschläger M,
Ketpura NI et al.
(2001)
Proteolytic cleavage of Chordin as a switch for the dual activities of twisted gastrulation in BMP signaling.
Development
128:
4439–4447.
Lavery K,
Swain P,
Falb D and
Alaoui‐Ismaili MH
(2008)
BMP‐2/4 and BMP‐6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow‐derived mesenchymal stem cells.
Journal of Biological Chemistry
283:
20948–20958.
Lee KS,
Kim HJ,
Li QL et al.
(2000)
Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast‐specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.
Molecular and Cellular Biology
20:
8783–8792.
Lehmann K,
Seemann P,
Stricker S et al.
(2003)
Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2.
Proceedings of the National Academy of Sciences of the USA
100:
12277–12282.
Monzen K,
Hiroi Y,
Kudoh S et al.
(2001)
Smads, TAK1, and their common target ATF‐2 play a critical role in cardiomyocyte differentiation.
Journal of Cell Biology
153:
687–698.
Nishitoh H,
Ichijo H,
Kimura M et al.
(1996)
Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor‐5.
Journal of Biological Chemistry
271:
21345–21352.
Onichtchouk D,
Chen YG,
Dosch R et al.
(1999)
Silencing of TGF‐β signalling by the pseudoreceptor BAMBI.
Nature
401:
480–485.
Piccirillo SGM,
Reynolds BA,
Zanetti N et al.
(2006)
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour‐initiating cells.
Nature
444:
761–765.
Rosenzweig BL,
Imamura T,
Okadome T et al.
(1995)
Cloning and characterization of a human type II receptor for bone morphogenetic proteins.
Proceedings of the National Academy of Sciences of the USA
92:
7632–7636.
Sapkota G,
Alarcón C,
Spagnoli FM et al.
(2007)
Balancing BMP signaling through integrated inputs into the Smad1 linker.
Molecular Cell
25:
441–454.
Savage C,
Das P,
Finelli AL et al.
(1996)
Caenorhabditis elegans genes sma‐2, sma‐3 and sma‐4 define a conserved family of transforming growth factor β pathway components.
Proceedings of the National Academy of Sciences of the USA
93:
790–794.
Sekelsky C,
Newfeld SJ,
Rafterg LA et al.
(1995)
Genetic characterization and cloning of mothers against Dpp, a gene required for decapentaplegic function in Drosophila melanogaster.
Genetics
139:
1347–1358.
Shen R,
Chen M,
Wang YJ et al.
(2006)
Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1‐induced Runx2 degradation.
Journal of Biological Chemistry
281:
3569–3576.
Shibuya H,
Iwata H,
Masuyama N et al.
(1998)
Role of TAK1 and TAB1 in BMP signaling in early Xenopus development.
EMBO journal
17:
1019–1028.
Shore EM,
Xu M,
Feldman GJ et al.
(2006)
A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.
Nature Genetics
38:
525–527.
Storm EE,
Huynh TV,
Copeland NG et al.
(1994)
Limb alterations in brachypodism mice due to mutations in a new member of the TGF β‐superfamily.
Nature
368:
639–643.
Urist MR
(1965)
Bone: formation by autoinduction.
Science
150:
893–899.
Wang Q,
Wei X,
Zhu T et al.
(2007)
Bone morphogenetic protein 2 activates Smad6 gene transcription through bone‐specific transcription factor Runx2.
Journal of Biological Chemistry
282:
10745–10742.
Wozney JM,
Rosen V,
Celeste AJ et al.
(1988)
Novel regulators of bone formation: molecular clones and activities.
Science
242:
1528–1534.
Wrana JL,
Attisano L,
Wieser R et al.
(1994)
Mechanism of activation of the TGF‐β receptor.
Nature
370:
341–347.
Zhang Y,
Feng X‐H,
We R,
Derynck R et al.
(1996)
Receptor‐associated Mad homologues synergize as effectors of the TGF‐β response.
Nature
383:
168–172.
Zhao G‐Q
(2003a)
Consequences of knocking out BMP signalling in the mouse.
Genesis
35:
43–56.
Zhao M,
Qiao M,
Oyajobi BO et al.
(2003b)
E3 ubiquitin ligase Smurf1 mediates core‐binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation.
Journal of Biological Chemistry
278:
27939–27944.
Further Reading
Canalis E,
Economides AN and
Gazzerro E
(2003)
Bone morphogenetic proteins, their receptors, and the skeleton.
Endocrine Reviews
24:
218–235.
Chen D,
Zhao M and
Mundy GR
(2004)
Bone morphogenetic proteins.
Growth Factors
22:
233–241.
Feng XH and
Derynk R
(2005)
Specificity and versatility in TGF‐β signalling through Smads.
Annual Review of Cell and Developmental Biology
21:
659–693.
Miyazama K,
Shinozaki M,
Hara T et al.
(2002)
Two major Smad pathways in TGF‐β superfamily signalling.
Genes to Cells
7:
1191–1204.
Reddi AH
(1997)
Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogenes.
Cytokine and Growth Factor Reviews
8:
11–20.
Schmierer B and
Hill CS
(2007)
TGFβ‐SMAD signal transduction: molecular specificity and functional flexibility.
Nature Reviews Molecular Cell Biology
8:
970–982.
Thomas JT,
Lin K,
Nadedkar M et al.
(1996)
A human chondroplasia due to a mutation in a TGF‐β superfamily member.
Nature Genetics
12:
315–317.
Winnier G,
Blessing M,
Labosky PA and
Hogan BL
(1995)
Bone morphogenetic protein‐4 is required for mesoderm formation and patterning in the mouse.
Genes and Development
9:
2105–2116.
Zhou H and
Niswander L
(1996)
Requirement for BMP signalling in interdigital apoptosis and scale formation.
Science
272:
738–741.